| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/20/2015 | CA2546452C Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 01/20/2015 | CA2514277C Methods and compositions for administering therapeutic and diagnostic agents |
| 01/20/2015 | CA2498000C Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 01/15/2015 | WO2015006744A1 Immunoglobulin fusion proteins and compositions thereof |
| 01/15/2015 | WO2015006689A1 Treatment and diagnosis of cancer and precancerous conditions using pde10a inhibitors and methods to measure pde10a expression |
| 01/15/2015 | WO2015006592A1 N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer |
| 01/15/2015 | WO2015006591A1 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
| 01/15/2015 | WO2015006492A1 Kinase inhibitors for the treatment of disease |
| 01/15/2015 | WO2015006482A1 CERTAIN IMPROVED HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 01/15/2015 | WO2015006429A1 Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery |
| 01/15/2015 | WO2015006193A1 Tricyclic heterocycles as bet protein inhibitors |
| 01/15/2015 | WO2015005823A1 Methods for detecting, treating and preventing urinary tract inflammation/infection |
| 01/15/2015 | WO2015005723A1 Cell-penetrating peptide and conjugate comprising same |
| 01/15/2015 | WO2015005670A1 LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME |
| 01/15/2015 | WO2015005669A1 LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME |
| 01/15/2015 | WO2015005479A1 Tumor antigen peptide |
| 01/15/2015 | WO2015005473A1 Method of predicting response of cancer to treatment |
| 01/15/2015 | WO2015005466A1 Method for producing lipid having high eicosapentaenoic acid content |
| 01/15/2015 | WO2015005253A1 Novel lipid |
| 01/15/2015 | WO2015004636A1 A pharmaceutical combination for the treatment of melanoma |
| 01/15/2015 | WO2015004618A1 Enhancer of zeste homolog 2 inhibitors |
| 01/15/2015 | WO2015004610A1 1,5-dihydropyrrol-2-one derivatives as inhibitors of p53-mdm2/mdm4 protein-protein interaction |
| 01/15/2015 | WO2015004481A1 Imidazo-condensed bicycles as inhibitors of discoidin domain receptors (ddrs) |
| 01/15/2015 | WO2015004395A1 Novel salt of 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, preparation thereof and formulations containing same |
| 01/15/2015 | WO2015004212A1 Inhibitor of neuropilin and use thereof for the treatment of neuropilin-related diseases |
| 01/15/2015 | WO2015004149A1 Tricyclic pyrrole compounds, their preparation and use in medicaments |
| 01/15/2015 | WO2015004075A1 Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones |
| 01/15/2015 | WO2015004024A1 Substituted pyrazolo-pyridinamines |
| 01/15/2015 | WO2015003747A1 Composition containing modified derivatives of a cytidine antimetabolite for the treatment of susceptible disease |
| 01/15/2015 | WO2015003641A1 Therapeutically active compounds and their methods of use |
| 01/15/2015 | WO2015003640A1 Therapeutically active compounds and their methods of use |
| 01/15/2015 | WO2015003571A1 Novel crystal form of dabrafenib mesylate and preparation method thereof |
| 01/15/2015 | WO2015003411A1 Combined preparation and use thereof for preparing non-small cell lung cancer drug |
| 01/15/2015 | WO2014089379A9 Compounds useful as inhibitors of atr kinase |
| 01/15/2015 | US20150018552 N-Phenyl-2-pyrimidine-amine Derivatives |
| 01/15/2015 | US20150018526 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 01/15/2015 | US20150017175 Methods of administering anti-tnfalpha antibodies |
| 01/15/2015 | US20150017173 Antibodies to human transmembrane proteins |
| 01/14/2015 | EP2824181A1 Novel fgfr3 fusion product |
| 01/14/2015 | EP2824114A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/14/2015 | EP2824108A1 Tetracyclic anthraquinone derivatives |
| 01/14/2015 | EP2824105A1 Indolopyridines as Eg5 kinesin modulators |
| 01/14/2015 | EP2824102A1 Androgen receptor modulators and uses thereof |
| 01/14/2015 | EP2824100A1 1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2015 | EP2824099A1 Novel triazine derivative |
| 01/14/2015 | EP2823825A1 Pharmaceutical composition for treating cancer |
| 01/14/2015 | EP2823824A1 Pharmaceutical composition containing peptide |
| 01/14/2015 | EP2823816A1 Inhibitors of Neuropilin and use thereof for the treatment of Neuropilin-related diseases |
| 01/14/2015 | EP2822955A1 Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer |
| 01/14/2015 | EP2822953A1 Macrocyclic derivatives for the treatment of proliferative diseases |
| 01/14/2015 | EP2822945A1 Aminomethylene pyrazolones with therapeutic activity |
| 01/14/2015 | EP2822944A1 Oxazolidinone compounds and derivatives thereof |
| 01/14/2015 | EP2822932A2 Solid state forms of cabazitaxel and processes for preparation thereof |
| 01/14/2015 | EP2822931A1 Triazolone compounds and uses thereof |
| 01/14/2015 | EP2822656A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| 01/14/2015 | EP2822601A1 Micrornas and uses thereof |
| 01/14/2015 | EP2822588A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 01/14/2015 | EP2822575A1 Engineered antibody-interferon mutant fusion molecules |
| 01/14/2015 | EP2822573A1 Treatment of cancer |
| 01/14/2015 | EP2822558A2 Procaspase 3 activation by combination therapy |
| 01/14/2015 | EP2822546A1 Procaspase combination therapy for glioblastoma |
| 01/14/2015 | CN104284896A 取代的咪唑并哒嗪 Substituted imidazopyridazine |
| 01/14/2015 | CN104284675A 具有抗肿瘤活性的新颖结合分子 Novel anti-tumor activity of binding molecules |
| 01/14/2015 | CN104278046A 乙型肝炎病毒和沙眼衣原体嵌合核酸疫苗及其用途 Hepatitis B virus and Chlamydia trachomatis chimeric DNA vaccine and its use |
| 01/14/2015 | CN104278037A 基于变异应答调制Toll 样受体的免疫调节寡核苷酸(IRO)化合物 Oligonucleotide-based mutation regulate Toll-like receptor responses immune modulation (IRO) compound |
| 01/14/2015 | CN104277209A 一种聚电解质三元共聚物及其纳米胶束的制备 An electrolyte terpolymer poly and micelles prepared |
| 01/14/2015 | CN104277137A 区域选择性合成圆头蒿多糖磷酸酯的方法及应用 Selective Synthesis of polysaccharide round Artemisia phosphate method and application area |
| 01/14/2015 | CN104277134A 一种具有抗肿瘤活性的竹荪多糖-锌螯合物的制备方法及其应用 An anti-tumor activity of bamboo fungus polysaccharides - zinc chelate preparation method and its application |
| 01/14/2015 | CN104277130A 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 A sulfated polysaccharide esterified poly guluronic acid or a pharmaceutically acceptable salts and their preparation and use |
| 01/14/2015 | CN104277117A 与磷脂酰丝氨酸结合的Fc融合构建体及其治疗用途 Phosphatidylserine bound Fc fusion constructs and therapeutic use |
| 01/14/2015 | CN104277094A Dc靶向肽及其应用 Dc targeting peptide and its application |
| 01/14/2015 | CN104277082A 一种新型抗肿瘤药物 A new anticancer drugs |
| 01/14/2015 | CN104277051A 4-氨基-噻吩并[3,2-c]吡啶-7-羧酸衍生物 4-Amino - thieno [3,2-c] pyridine-7-carboxylic acid derivative |
| 01/14/2015 | CN104277047A 一种具有葡萄糖转运体亲和力的靶向功能分子 Targeting functional molecules having affinity glucose transporter |
| 01/14/2015 | CN104277035A 吖啶-1,3,4-噻二唑类化合物及其制备方法和应用 Acridine 1,3,4-thiadiazole compound and preparation method and application |
| 01/14/2015 | CN104277029A 吖啶-1,2,3-三唑类化合物及其制备方法和应用 Acridine-1,2,3-triazole compounds and its preparation method and application |
| 01/14/2015 | CN104277028A 吖啶-1,2,4-三唑-5-硫酮化合物及其制备方法和应用 Acridine-1,2,4-triazole-5-thione compound and preparation method and application |
| 01/14/2015 | CN104276994A 3,3′-双取代氧化吲哚与3-烯键氧化吲哚拼接衍生物及其制备方法及应用 3,3'-bis-substituted indole oxidation and oxidation of indole-3- ethylenic derivatives splicing and preparation method and application |
| 01/14/2015 | CN104276962A 一种阿司匹林衍生物及其组合物与应用 One kind of aspirin derivatives, and combinations thereof and Applications |
| 01/14/2015 | CN104276960A 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Tapentadol hydrochloride and celecoxib its eutectic composition and preparation methods |
| 01/14/2015 | CN104274841A 肿瘤血管栓塞剂以及金纳米粒子的用途 Uses tumor embolization agents and gold nanoparticles |
| 01/14/2015 | CN104274837A 一种尼洛替尼口服制剂 One kind of nilotinib oral formulation |
| 01/14/2015 | CN104274834A 一种环境敏感的肿瘤靶向聚合物胶束及其制备方法 An environmentally sensitive tumor targeting and preparation of polymeric micelles |
| 01/14/2015 | CN104274780A 一种以维生素c和姜黄素为主药成分的口含片 A kind of vitamin c and buccal tablets of curcumin-based drug ingredient |
| 01/14/2015 | CN104274773A 一种治疗癌症和抗击病毒的中药及其制备方法 A method for treating cancer and medicine to fight the virus and its preparation method |
| 01/14/2015 | CN104274766A 一种对肿瘤化疗具有减毒增效的中药组合物及其制备方法 A combination of chemotherapy with a traditional Chinese medicine and its preparation method attenuated synergistic |
| 01/14/2015 | CN104274765A 一种对肿瘤化疗具有减毒增效的中药组合物及其制备方法 A combination of chemotherapy with a traditional Chinese medicine and its preparation method attenuated synergistic |
| 01/14/2015 | CN104274759A 一种白血病化疗后调补的中药药膳配方及其制备方法 Chinese medicinal herbs recipe and preparation method of leukemia after chemotherapy tune up |
| 01/14/2015 | CN104274747A 一种抗肿瘤的中药制剂 An anti-cancer traditional Chinese medicine |
| 01/14/2015 | CN104274681A 一种放疗术后调补的中药药膳配方及其制备方法 Postoperative radiotherapy tune up one kind of medicine Diet recipes and preparation methods |
| 01/14/2015 | CN104274586A 治疗妇科疾病的药物及其制备方法 Treatment of gynecological diseases and its preparation method |
| 01/14/2015 | CN104274544A 一种治疗肝癌的中药汤剂 A treatment for liver cancer decoction |
| 01/14/2015 | CN104274506A 一种防风挥发油的制备方法及其应用 A method of preparing volatile oil windproof and its application |
| 01/14/2015 | CN104274501A 药物组合物及其制备方法 The pharmaceutical composition and preparation method |
| 01/14/2015 | CN104274498A 一种高效抗肿瘤灵芝提取物及其制备方法 An efficient anti-tumor Ganoderma extract and its preparation method |
| 01/14/2015 | CN104274495A 长存剂(中药抗癌剂) Forever agent (anticancer medicine) |
| 01/14/2015 | CN104274489A 一种用于治疗肿瘤的联合用药物 A combined treatment of cancer with drugs for |
| 01/14/2015 | CN104274481A 治疗肝癌的药物 Treatment of liver cancer drug |
| 01/14/2015 | CN104274442A 癌症的治疗 Treatment of cancer |
| 01/14/2015 | CN104274429A 环阿尔廷型三萜化合物在制备抗肺癌药物中的应用 Ring A Erting type triterpenoids in the preparation of anti-cancer drug application |